The development of possible vaccines for the Covid-19 virust are advancing at a record pace, raising hopes that will be available for large-scale distribution in 18 to 24 months. The global distribution must be on an equitable basis. To achieve that, there are five investment priorities: financing the purchase of vaccines, strengthening and protecting the health care workforce, creating a system for reliably identifying the residents of developing countries, leveraging data to predict behavior, and establishing reliable supply chains.
In these difficult times, we’ve made a number of our coronavirus articles free for all readers. To get all of HBR’s content delivered to your inbox, sign up for the Daily Alert newsletter.
With the development of potential vaccines for Covid-19 progressing quickly, we need to invest now in infrastructure for distributing a vaccine globally on an equitable basis as soon as it is proven safe and effective.
